Retreatment with Sofosbuvir/Velpatasvir/Voxilaprevir for 12 weeks is safe and effective for patients who have previously received Sofosbuvir/Velpatasvir or Sofosbuvir/ Velpatasvir/Voxilaprevir

Ruane, P; Strasser, SJ; Gane, EJ; Hyland, RH; Shao, J; Dvory-Sobol, H; Tran, T; Stamm, LM; Brainard, DM; Nyberg, L; Shafran, S

JOURNAL OF VIRAL HEPATITIS, 2018; 25 (): 193